Try our beta test site
301 studies found for:    Open Studies | "Multiple Sclerosis"
Show Display Options
Rank Status Study
1 Recruiting Phase 2 Study of Ublituximab in Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: Ublituximab;   Drug: Placebo
2 Recruiting Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: ponesimod;   Drug: teriflunomide
3 Not yet recruiting Use of an Electronic Diary by People With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Device: e-diary
4 Not yet recruiting A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period
Condition: Multiple Sclerosis
Intervention: Drug: Teriflunomide
5 Recruiting Swiss Multiple Sclerosis Registry
Condition: Multiple Sclerosis
Intervention:
6 Not yet recruiting A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: NeuroVax;   Biological: IFA Incomplete Freund's Adjuvant
7 Recruiting Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention:
8 Recruiting Pathological Basis of MRI Signal Changes in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
9 Recruiting Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study
Condition: Multiple Sclerosis
Interventions: Procedure: Hematopoietic Stem Cell Therapy;   Drug: Standard treatment with a conventional drug
10 Recruiting Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Interferon beta-1a i.m. injections;   Drug: Fingolimod oral capsules;   Drug: Placebo oral capsule;   Drug: Placebo i.m. injection
11 Recruiting Pilot Diet Study for Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Behavioral: Dietary Intervention;   Behavioral: Non-dietary Intervention Arm
12 Recruiting Calorie Restriction in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Intervention: Other: Calorie restriction
13 Recruiting Trekking Poles to Aid Multiple Sclerosis Gait Impairment
Condition: Multiple Sclerosis
Interventions: Other: No device;   Device: Single-point cane (SPC);   Device: Four-point cane (FPC);   Device: Trekking pole (TP).
14 Recruiting Safety and Tolerability of Quetiapine in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Extended-release quetiapine fumarate
15 Recruiting Motivation of Patients Diagnosed With Multiple Sclerosis to Become Citizen Researchers
Condition: Multiple Sclerosis
Intervention: Other: Qualitative evaluation
16 Recruiting MEsenchymal StEm Cells for Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Mesenchymal stem cells;   Drug: Suspension media
17 Not yet recruiting A Reeducation Program to Effort to Improve the Walking of Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Intervention: Other: Effort reeducation program
18 Recruiting Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Procedure: Blood sampling;   Other: Gustatory sensitivity test using Taste strips;   Other: Questionnaires
19 Recruiting Plasma Exchanges in Multiple Sclerosis (MS) Relapses
Conditions: Multiple Sclerosis;   Multiple Sclerosis, Acute Relapsing
Interventions: Procedure: plasma exchange;   Procedure: sham exchanges procedure
20 Recruiting Intensity Depended Impacts on Cognitive Functions in Persons With Multiple Sclerosis - a Pilot Study
Condition: Multiple Sclerosis
Interventions: Behavioral: Exercise;   Behavioral: Relaxation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.